A Study Of The Efficacy Of Atorvastatin For Lowering Cholesterol In High-Risk Patients With High Cholesterol
Clinical trial NCT00644670 · COMPLETED
Trial details
- NCT number
- NCT00644670
- Sponsor
- Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2003-06-01
- Enrollment
- 232
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.